Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
1.070
0.00 (0.00%)
At close: Dec 12, 2025, 4:00 PM EST
1.050
-0.020 (-1.87%)
After-hours: Dec 12, 2025, 4:59 PM EST
Trinity Biotech Market Cap
Trinity Biotech has a market cap or net worth of $19.87 million as of December 12, 2025. Its market cap has increased by 85.73% in one year.
Market Cap
19.87M
Enterprise Value
115.46M
1-Year Change
85.73%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since October 9, 1997, Trinity Biotech's market cap has decreased from $44.82M to $19.87M, a decrease of -55.68%. That is a compound annual growth rate of -2.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 19.87M | 29.52% |
| Dec 31, 2024 | 15.34M | -6.42% |
| Dec 29, 2023 | 16.39M | -56.55% |
| Dec 30, 2022 | 37.73M | 26.22% |
| Dec 31, 2021 | 29.89M | -62.47% |
| Dec 31, 2020 | 79.64M | 268.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |